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Very elderly patients (i.e., 80years) are disproportionally affected by acute ischemic
stroke. They account for a third of hospital stroke admissions, but two-thirds of overall
stroke-related morbidity and mortality.There is some evidence of clinical beneﬁt in treating
selected very elderly patients with intravenous thrombolysis (IVT). For very elderly patients
ineligible or non-responsive to IVT, intra-arterial therapy (IAT) may have promise in improv-
ing clinical outcome. However, its unequivocal efﬁcacy in the general population remains
to be proven in randomized trials. Small cohort studies reveal that the rate of good clinical
outcome for very elderly patients after IAT is highly variable, ranging from 0 to 28%. In
addition, they experience higher rates of futile reperfusion than younger patients. Thus,
it is imperative to understand the factors that impact on clinical outcome in very elderly
patients after IAT.The aim of this review is to examine the factors that may be responsible
for the heterogeneous clinical response of the very elderly to IAT.This will allow the reader
to integrate the current available evidence to individualize intra-arterial stroke therapy in
very elderly patients. Placing emphasis on pre-stroke independent living, smaller infarct
core size, short procedure times, and avoiding general anesthesia where feasible, will help
improve rates of good clinical outcome.
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INTRODUCTION
Almost one-third of new ischemic strokes occur in patients aged
80years or older (1). In this very elderly cohort,ischemic stroke is
associated with more severe neurological impairment and higher
morbidity and mortality rates, compared to non-elderly patients
(2). The Third International Stroke Trial (IST-3) demonstrated
the likely clinical beneﬁt of intravenous thrombolysis (IVT) in
very elderly stroke patients (3). For patients ineligible or non-
responsive to intravenous thrombolysis, intra-arterial therapy
(IAT) may have promise in improving clinical outcome. How-
ever, its efﬁcacy in younger stroke patients remains to be proven
in randomized trials. Cohort studies reveal that the rate of good
clinical outcome after very elderly patients are treated with IAT is
heterogeneous, ranging from 0 to 28% (4–10). In addition, close
to 50% of elderly patients experience futile reperfusion, i.e., 90-
day follow-up modiﬁed Rankin scale (mRS) score of 3–6, despite
thrombolysis in cerebral infarction (TICI) 2B-3 reperfusion and
Abbreviations: DNR, do not resuscitate; ECASS, European Cooperative Acute
Stroke Study; IAT, intra-arterial therapy; IST-3, Third International Stroke Trial;
IVT, intravenous thrombolysis; ivtPA, intravenous tissue plasminogen activator;
mRS, modiﬁed Rankin scale; NIHSS, National Institutes of Health Stroke Scale;
NINDS, National Institute of Neurological Disorders and Stroke; sICH, sympto-
maticintracranialhemorrhage;SITS-MOST,SafeImplementationof Thrombolysis
in Stroke-Monitoring Study; SWIFT, Solitaire With Intention for Thrombectomy;
TICI, thrombolysis in cerebral infarction; TREVO2, Trevo vs. Merci retrievers for
thrombectomy revascularization of large vessel occlusions in acute ischemic stroke.
no intracranial hemorrhage (11). This is almost double the rate of
futile reperfusion for younger patients. These facts could lead to
treating physician reluctance to offer very elderly patients intra-
arterial stroke therapy. Thus, to individualize intra-arterial stroke
therapydecisionsinveryelderlypatients,there isacriticalneedto
understand the factors that impact on clinical outcome.
The aim of this focused review is to examine the factors that
may be responsible for this heterogeneity in clinical outcome in
thisgrowingpopulationof veryelderlystrokepatientsundergoing
IAT.Thiswillallowthereadertointegratethecurrentavailableevi-
dencewiththeirownclinicalexpertiseandpatientwishestomake
the most appropriate clinical decision for very elderly patients
being considered for intra-arterial stroke therapy.
WHY EXAMINE OUTCOMES IN VERY ELDERLY PATIENTS?
Theworldwideincidenceofﬁrst-everstrokein2005wasestimated
at 16 million, with 5.7 million stroke-related deaths (12). This is
expectedtoriseto23millionstrokesand7.8milliondeathsby2030
(12). This increase is largely driven by the rapidly growing elderly
population – in the United States, the population aged greater
than 85years is expected to increase ﬁvefold by 2050 (13). These
expanding numbers of the very elderly will produce an increasing
burdenofage-associateddisease,mandatingaclearunderstanding
of treatment options for this population.
After ischemic stroke admission, very elderly patients experi-
ence greater disability and are less likely to be discharged home,
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even if they receive similar rates of stroke care quality metrics as
younger patients (14). Despite treatment with either IVT or IAT,
there remain higher rates of in-hospital mortality than younger
patients (15). Even after adjustment for differences in stroke risk
factorsandcomorbidities,theycontinuetohavepoorerfunctional
outcomes (2). Ultimately, elderly patients account for only one-
third of all admissions but almost two-thirds of all stroke deaths
(2). This disproportionate effect of ischemic stroke on the elderly
will continue to grow signiﬁcantly in the future.
WHAT HAVE WE LEARNED LATELY ABOUT ACUTE STROKE
THERAPY IN ELDERLY PATIENTS?
For many years, there has been a paucity of high quality evi-
dence for acute stroke therapy in elderly patients. Only 42 elderly
patients were included in The National Institute of Neurological
Disorders and Stroke (NINDS) intravenous tissue plasminogen
activator (ivtPA) trial (16, 17) and they were excluded from the
largeIVTtrialssuchtheEuropeanCooperativeAcuteStrokeStudy
(ECASS) III (18) and Safe Implementation of Thrombolysis in
Stroke-Monitoring Study (SITS-MOST) (19).
A previous non-randomized controlled comparison of the
SITS-International Stroke Thrombolysis Registry and Virtual
InternationalStrokeTrialsArchiveincluded3,439veryelderly(age
>80)patients(totaln D29228)(20).Althoughincreasingagewas
associated with poorer outcome, the association between throm-
bolysis and improved outcome was maintained in very elderly
patients. Recently,the results of the IST-3,an international multi-
center randomized controlled trial of IVT within 6h of ischemic
stroke onset, were published (3). This included the largest cohort
ofelderlypatientsinarandomizedcontrolledIVTtrialtodate(age
>80; n D1617; total n D3035). Although IST-3 failed to reach its
primaryendpoint,secondaryanalysisrevealedthattreatmentben-
eﬁt was greatest in the 0–3h cohort, with 30.6% of those treated
with ivtPA alive and independent at 6months compared to 22.7%
of controls. The vast majority (n D726/849) included in this 0–
3h cohort were >80years, and the treatment beneﬁt in patients
>80years was at least as large as younger patients. Thus,potential
treatment beneﬁt from IVT does likely extend to elderly patients.
In contrast, there is no high quality randomized controlled
data reporting on clinical outcomes of IAT in the elderly. The
large IAT trials, including the recent three trials published in the
New England Journal of Medicine, all excluded elderly patients
greater than 85years or did not reported age-related outcomes
(21–28). The smaller case cohort studies have all reported quite
variableclinicaloutcomes.Asdeﬁnedby90-daymRS2,therates
of good clinical outcome in elderly patients range from 0 to 28%
(4–10). Table 1 summarizes data from current published stud-
ies designed to assess clinical outcome after very elderly patients
with anterior circulation stroke are treated with IAT. These stud-
ies include patients treated with intra-arterial thrombolysis, and
older generation mechanical devices such as the Merci Retrieval
System (Concentric Medical, Mountain View, CA, USA) and the
PenumbraSystem(Penumbra,Alameda,CA,USA)thathavelower
reperfusion rates compared to modern intra-arterial stentrievers.
There is a paucity of data on outcomes of elderly patients
treated with these stentriever devices – the Solitaire With Inten-
tionforThrombectomy(SWIFT)andTrevovs.Merciretrieversfor
thrombectomyrevascularizationoflargevesselocclusionsinacute
ischemic stroke (TREVO2) trials excluded patients >85years,and
no age-stratiﬁed outcomes for older patients have been reported
(31, 32). The large prospective single-arm study of patients with
large vessel anterior circulation strokes treated using the solitaire
FR stentriever also excluded patients aged >84years (33). Simi-
larly, the prospective European TREVO trial excluded those aged
>85years (34).
Notably, a recent abstract published from the North Ameri-
can Solitaire Stent Retriever Acute Stroke registry did include 64
very elderly patients and compared outcomes to 245 non-elderly
patients (35). Despite similar rates of reperfusion (TICI2a)
and symptomatic intracranial hemorrhage (sICH), very elderly
patients had signiﬁcant lower rates of good clinical outcome (90-
day mRS 2: 27 vs. 45%; P D0.007) and higher mortality (42 vs.
27%:P D0.03)comparedtoyoungerpatients.TheTrevoRetriever
RegistryhasalsobeenrecentlylaunchedintheUStoassessthereal
world performance of the Trevo Retriever. There is no upper age
limit,andthiswillprovidefurtherdatafortheveryelderlycohort.
WHY ARE CLINICAL OUTCOMES HETEROGENEOUS?
There are many factors that impact on the clinical outcome of
patients undergoing IAT. In elderly patients, pre-stroke disability,
baseline infarct size, cerebral collateral circulation, use of general
anesthesia, and procedural time are prominent factors. In addi-
tion,thereareconcernsthatveryelderlypatientshavehigherrates
of post-treatmenthemorrhage,andsigniﬁcantdifferencesinpost-
treatment care that could negatively impact on clinical outcome.
So what have we learnt lately?
PRE-STROKE DISABILITY
Pre-stroke disability and institutionalization (not living at home)
are independent predictors of post-stroke death and disability in
elderly stroke patients (1, 36). These are common in the elderly
stroke cohort – almost half of elderly patients hospitalized for
index stroke have a pre-stroke mRS of 2–5, while one in seven
are institutionalized prior to admission (1). In spite of these facts,
most studies of IAT in elderly patients have not reported rates of
baseline disability and institutionalization. Approximately, one-
third of the single center elderly cohort reported by Chandra et al.
had baseline mRS >1;2% of patients had a good clinical outcome
(5). Thirteen percent of the cohort examined by Kurre et al. had
pre-strokemRSscoresof3–4;17%oftheoverallcohorthadagood
clinical outcome (7). Patients with baseline mRS scores >1 were
excluded from the cohort by Mono et al.; 28% of elderly patients
hadagoodclinicaloutcome(9).Nevertheless,elderlypatientshad
signiﬁcantly lower rates of good clinical outcome and higher rates
of mortality than younger patients in both cohorts, suggesting
that there are additional factors responsible for the worse clinical
outcomes among the very elderly.
BASELINE INFARCT SIZE
Thereareemergingdatathatelderlystrokepatientsrequiresmaller
baselineinfarctstoachievegoodclinicaloutcomewhencompared
to younger patients. In patients undergoing IAT, ﬁnal infarct vol-
ume is a powerful predictor of clinical outcome (37, 38). With
increasing age, the post-treatment infarct volume that predicts
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Table 1 | Summary of current published studies designed to assess clinical outcome after very elderly patients with anterior circulation stroke
undergo IAT.
Author
(year)
Age used to
deﬁne elderly
cohort
Number of
very elderly
patients
Number of
younger
controls
sICH rate
in elderly
cohort
Primary
outcome
measures
Summary of primary outcome
Singer
et al. (11)
77 Registry of
362 patients;
25% of cohort
>76; 91
patients
Registry of
362 patients;
75% of cohort
18–76years;
271 patients
Not reported;
3% ECASS
parenchymal
hematoma
type II in total
cohort
90-day mRS
and “futile
recanalization”
Outcome is age-dependent with elderly patients (in
the highest age quartile of 77–94years) having the
lowest rates of good outcome (mRS 0–2) of 17%
compared to 60% for patients in the lowest age
quartile (18–56years). Elderly (77–94years)
patients had higher rates (46 vs. 24%) of clinically
“futile recanalization” (deﬁned as 90-day mRS
score 3 despite successful recanalization and no
subsequent hemorrhage) compared the lowest age
quartile (18–56years)
Kurre
et al. (7)
80 109 0 6% ECASS
parenchymal
hematoma
type II
90-day mRS 13% had pre-stroke disability of mRS score 3–4. By
90days, 17% of elderly patients had a mRS score
0–2; mortality rate was 48%
Willey
et al. (15)
80 186 622 Not reported In-hospital
mortality
Very elderly patients had a higher risk of in-hospital
mortality compared with younger counterparts
regardless of treatment modality (IAT and/or IVT)
(OR, 2.13; 95% CI, 1.60–2.84). IAT does not
increase the risk of in-hospital mortality in very
elderly patients compared to IVT alone
Chandra
et al. (5)
80 49 130 4% ECASS
parenchymal
hematoma
type II
90-day mRS
and mortality
Very elderly patients had signiﬁcantly lower rates of
good outcome (mRS 0–2: 2 vs. 33%; P <0.0001)
and higher mortality (59 vs. 24%; P <0.0001) at
90days compared to younger patients
Mono
et al. (9)
80 43 524 2% 90-day mRS
and mortality
Very elderly patients had signiﬁcantly lower rates of
good outcome (mRS 0–2: 28 vs. 46%; P D0.019)
and higher mortality (40 vs. 22%; P D0.0008) at
90days compared to younger patients
Ghobrial
et al.
(29)
75 51 patients
aged 75 or
greater
0 6% Discharge
mRS
At time of discharge, 33% of elderly patients had a
mRS score 0–3; mortality rate at discharge was
22%
Arkadir
et al. (4)
80 14 66 7% 90-day mRS Very elderly patients had signiﬁcantly lower rates of
good outcome (mRS 0–2: 0 vs. 41%; P D0.008)
Mazighi
et al. (8)
80 25 59 12% 90-day mRS Very elderly patients had signiﬁcantly lower rates of
good outcome (mRS 0–2: 28 vs. 64%; P D0.002)
and higher mortality (40 vs. 22%; P D0.002) at
90days compared to younger patients
Loh
et al.
(30)
80 31 75 11% mRS at
discharge and
stroke-related
death
Very elderly patients had lower rates (not
statistically signiﬁcant) of good outcome (mRS 0–2:
19 vs. 33%; P D0.17) at discharge compared to
younger patients. Rates of stroke-related death
were signiﬁcantly higher in elderly patients (48 vs.
15%; P D0.0005) at discharge compared to
younger patients
(Continued)
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Table 1 | Continued
Author
(year)
Age used to
deﬁne elderly
cohort
Number of
very elderly
patients
Number of
younger
controls
sICH rate
in elderly
cohort
Primary
outcome
measures
Summary of primary outcome
Qureshi
et al. (10)
80 24 77 8% 30–90day
mRS and
mortality
Very elderly patients had lower rates (not
statistically signiﬁcant) of good outcome (mRS 0–2:
21 vs. 38%; P D0.21) at 30–90days compared to
younger patients.There were higher rates of
mortality (54 vs. 29%; P D0.02) as compared to
younger patients
Kim
et al. (6)
80 33 81 7% 90-day mRS Very elderly patients had signiﬁcantly lower rates of
good outcome (mRS 0–2: 26 vs. 40%; P D0.02)
and higher mortality (43 vs. 20%; P D0.01) at
90days compared to younger patients
All studies included small numbers of posterior circulation stroke patients, with the exception of Singer et al. (11), Chandra et al. (5), and Arkadir et al. (4) who only
included anterior circulation stroke.
good clinical outcome reduces (39). Target cut-off infarct volume
for predicting a good clinical outcome calculated from 24-h post
procedureCTscanssuggestsvolumesof approximately<50ccfor
patients <70years; <30cc for patients 70–79years; and <15cc
for those 80years (39). This is not surprising as elderly patients
have lesser neurological rehabilitation potential (40) and higher
rates of in-hospital medical complications after stroke, which is a
predictor for death and disability in elderly patients (36). None
of the current studies of IAT in the elderly report on exact base-
line infarct volumes. While intra-arterial selection criteria based
on baseline MR imaging may be able to accurately stratify these
volume thresholds, this is unlikely to occur with sufﬁcient accu-
racy using non-contrast CT or CT perfusion-based intra-arterial
selectionstrategies,particularlyearlyaftersymptomonset(41,42).
COLLATERAL CIRCULATION
There are conﬂicting data on whether elderly stroke patients with
anterior circulation occlusion have poorer leptomeningeal collat-
erals than younger patients. Collateral circulation can sustain the
ischemic brain tissue after vessel occlusion, and determines how
quicklyaninfarctgrowstocompleteitscourse.Patientswithgood
collaterals typically have smaller baseline infarcts and higher rates
of recanalization if treated with IAT (43, 44). If successful reper-
fusion occurs (TICI 2b-3), infarct growth is attenuated, and a
higher rate of good clinical outcome can be achieved (43, 44). It
has also been reported that every 10-year increment in age almost
doubles the odds of inadequate collateral circulation (45). Pro-
viding further support for this hypothesis of poorer collaterals
in older patients, collateral augmentation improved outcome in
elderly stroke patients in the recent safety and efﬁcacy of Neu-
roFlo Technology in ischemic stroke trial (46). A good clinical
outcome at 90days was two to four times more likely in elderly
patients treated with intermittent partial aortic balloon occlu-
sion to augment cerebral blood ﬂow and collateral circulation in
a sub-group of patients older than 70years. There was greater
beneﬁt for patients aged 80years and older, while no beneﬁt was
observed in patients younger than 70years. This demonstrates the
importance of the collateral circulation,particularly in the elderly
stroke patient.
ANESTHESIA
The use of general anesthesia has been linked to poorer outcomes
in patients undergoing IAT (47, 48) which may be accentuated in
elderly patients. The exact mechanism of poorer outcome after
general anesthesia is unclear. There is a major confounder in the
data published, as baseline National Institutes of Health Stroke
Scale(NIHSS)scoreswerehigherinthegeneralanesthesiacohort.
However,in a sub-group analysis of 494 patients (total n D1079),
controllingforNIHSS,generalanesthesiaremainedapredictorfor
poor outcome (47). The major postulate to explain this phenom-
enon is post-induction or intra-procedural reduction in blood
pressure impacting on cerebral collateral perfusion. This is sup-
portedbytherecentreportthatmaintainingalowestsystolicblood
pressure of >140mmHg is an independent predictor of good
neurological outcome after IAT (49). Post-induction hypotension
occurs more often in older patients, which could contribute to
poorer outcomes (50). In current reports of the elderly undergo-
ing IAT, the rate of usage of general anesthesia range from 40 to
100% (5,9,11,29),so this may be a signiﬁcant factor affecting the
currently published rates of good outcome.
Furthermore, it has also been shown that early neurocognitive
dysfunctioniscommoninpatientsundergoingcarotidendarterec-
tomy under general anesthesia (51). This phenomenon occurs at
a signiﬁcantly higher rate in older patients (51). Interestingly,ele-
vation of intra-operative mean arterial blood pressure during the
cross-clamp period during endarterectomy signiﬁcantly reduced
theincidenceof thisphenomenon,presumablybyoptimizationof
cerebral collateral perfusion (52). Thus, the elderly stroke patient
with a large vessel occlusion may be particularly vulnerable to the
negativeeffectsof hypotensionandgeneralanesthesiaduringIAT.
PROCEDURAL TIME
Vasculartortuosityandatheroscleroticburdenintheelderlystroke
populationmaycontributetolongerproceduraltimesthatinturn
negatively impacts on clinical outcome. Although no study has
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found a statistically signiﬁcant difference in symptom onset to
startorconclusionof IATinelderlypatientscomparedtoyounger
patients (5, 6, 9, 30), older age is associated with longer time to
access the target carotid artery in anterior circulation stroke (53).
Inthequarterof thetotalcohort(n D130)wherevesseltortuosity
resulted in greater than 30min delay in placing the guide catheter
into the target carotid artery, there was a signiﬁcant reduction
in the rate of reperfusion and good neurological outcome com-
pared to those with faster target vessel access. Notably, there was
nodifferenceinthetimefromsymptomonsettoﬁnalreperfusion.
POST-TREATMENT HEMORRHAGE
There is often concern that elderly patients have higher rates of
post-procedural hemorrhage compared to younger patients that
could lead to futile reperfusion by worsening patient outcome
or causing in-hospital mortality. However, in the cohort stud-
ies of elderly patients undergoing IAT, there were no signiﬁcant
differences in the rates of parenchymal hematoma (PH) type 2
[ECASS deﬁnition (54)] or sICH (5,6,8,9,30). The concern may
be in part due to the variability in deﬁnitions used in these stud-
ies and the small patient numbers. In an analysis of greater than
22,000 patients undergoing IVT,although there was no difference
in the rates of elderly patients experiencing sICH according to the
SITS-MOST deﬁnition,the rates of sICH according to the NINDS
deﬁnition were signiﬁcantly higher (20). Nonetheless, in a large
cohort study of anterior circulation stroke patients undergoing
IAT (n D1122), age was not a predictor of intracranial hemor-
rhage after IAT (55). Furthermore, in a large study of IAT in
elderly patients (n D1182), IAT did not increase the rates of in-
hospital mortality compared to intravenous thrombolysis alone
(15). Thus, it does not seem that the worse clinical outcomes and
higher mortality rates seen in elderly patients are attributable to
post-procedural hemorrhage.
POST-TREATMENT CARE
Elderly patients are more likely to have greater neurological
impairment,swallowingdifﬁculty,confusion,andurinaryinconti-
nenceduringhospitalizationforacutestrokecomparedtoyounger
patients(1).Theseareallriskfactorsforthedevelopmentof pneu-
monia, which accounts for up to third of in-hospital deaths after
ischemic stroke (56). In addition, elderly patients often have “do
notresuscitate(DNR)”ordersinplace.Inspiteofthesereferringto
patient wishes regarding cardiopulmonary resuscitation,the pres-
ence of these orders also leads to an overall reduction in physician
willingnesstotreat(57).Afterhemorrhagicstroke,thepresenceof
a DNR order leads to signiﬁcantly reduced rates of guideline rec-
ommended care, including stroke unit care (58). For the elderly
patientexperiencingaseverestroke,thedevelopmentof pneumo-
nia or lack of guideline recommended care could contribute to
poorer outcomes compared to younger patients.
FUTURE DIRECTIONS
Therealityisthatanischemicstrokeoccurringinanelderlypatient
is a severe life-threatening event. After their ﬁrst-ever ischemic
stroke,athirdofelderlypatientsarelikelytobedeadwithin30days
(59). Even after 12months, only a quarter have improved to mild
or no disability. In light of the frailty of the elderly population,
we may be unrealistic in our expectations that a high proportion
of elderly patients will have minimal disability after IAT. The data
that are currently available suggest that the clinical outcomes in
elderly patients undergoing IAT are heterogeneous, however rates
of no or mild disability as high as 28% have been reported. More-
over,performing IAT in the elderly has not raised safety concerns,
particularly with regard to post-treatment hemorrhage.
In light of the ﬁndings summarized in this review, individu-
alized patient selection for IAT appears more important in the
elderly stroke patient. Emphasis needs to be placed on pre-stroke
independent living, smaller infarct core size, short procedure
times, and avoiding general anesthesia where feasible. Multidis-
ciplinary screening and treatment protocols for post-stroke pneu-
moniawithminimizationof ventilatortimewillbealsoimportant
inoptimizingoutcomes.Inthefuture,invasivetechniquesforcol-
lateral augmentation may be found to have particular beneﬁt in
the elderly. Most importantly, while we must be realistic in our
expectations of clinical outcome, we should also not deny elderly
patients’ guideline recommended care. As selection criteria for
IAT in the elderly are reﬁned, and with more rapid and complete
reperfusion, the clinical outcome of elderly patients treated with
IAT should improve.
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